Central and Peripheral Fatigue in Individuals With Parkinson's Disease - Evaluation and Training
NCT ID: NCT01971528
Last Updated: 2024-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2012-12-18
2015-05-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Fatigue can be categorized into peripheral or central causes. The central fatigue and voluntary activation failure originate from the decrease in motivation or the reduction of the conduction within corticospinal tracts. Long term activation failure and central fatigue will cause disuse of muscle and result in peripheral weakness and peripheral fatigue. Quantifying the weighting of central versus peripheral factors contributing to the fatigue in people with PD is important.
Most of the conventional strength and endurance training programs were based on the researches of young groups. Almost no training program was design for enhancing the voluntary activation level and relief the central fatigue. Seeking an appropriate training program to enhance central activation is very important for individuals with PD who prone to fatigue.
Previous studies have shown that increasing afferent input by peripheral electrical stimulation (ES) at sensory threshold enhanced the plasticity of contralateral primary sensory cortex, the excitability of corticospinal tracts, and the functional performance in young adults. Combining afferent input with strength training was more effective than strength training along. ES, which is easy to quantify the dose of afferent input, is a feasible method to provide such training.
The purpose of this project is to investigate the effects of the combination of ES at sensory threshold and strength training on voluntary activation in the individuals with PD.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Establishing the Central and Peripheral Fatigue Indexes and VR Based Anti-fatigue Training Paradigm for Individuals With Parkinson Disease
NCT02017938
Examination of Factors Associated With Fatigue in Individuals Diagnosed With Parkinson's Disease
NCT06230939
Acupuncture in the Treatment of Fatigue in Parkinson's Disease
NCT02587754
Effects of a Multicomponent Protocol With Emphasis on Muscle Power Training on Bradykinesia in Individuals With Parkinson's Disease
NCT07172698
Resistance Training in Patients With Parkinson's Disease.
NCT02447146
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stage 1: Health control
pilot study: Establishing the central and peripheral contributing factors to the voluntary muscle strength loss during a fatiguing exercise in young and PD groups.
No interventions assigned to this group
Stage 1: PD subjects
pilot study: Establishing the central and peripheral contributing factors to the voluntary muscle strength loss during a fatiguing exercise in young and PD groups.
No interventions assigned to this group
Stage 2: Health subjects
pilot study: Finding optimal sensory stimulation parameters for PD individuals.
No interventions assigned to this group
Stage 2: PD subjects
pilot study: Finding optimal sensory stimulation parameters for PD individuals.
No interventions assigned to this group
Stage 3: PD subjects
Investigating the long-term effects of combined sensory stimulating strengthening program on the activation level and central fatigue in PD individuals.
Electronic muscle stimulator
Participants will perform 8 weeks of electrical stimulation for Quadriceps muscle belly(30 minutes/time, 3 times/week).
Muscle strength training
Participants will perform 8 weeks of isotonic contraction muscle strength training for lower extremities.
Stage 3: PD subjects (Control Subjects)
Investigating the long-term effects of combined sensory stimulating strengthening program on the activation level and central fatigue in PD individuals.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electronic muscle stimulator
Participants will perform 8 weeks of electrical stimulation for Quadriceps muscle belly(30 minutes/time, 3 times/week).
Muscle strength training
Participants will perform 8 weeks of isotonic contraction muscle strength training for lower extremities.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Osteoporosis.
* Diabetes.
PD subjects:
* Musculoskeletal injuries for knee.
* Osteoporosis.
* Diabetes.
* Any peripheral or central nervous system injury or disease patients.
20 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chang Gung University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ya-Ju Chang
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chang Gung University
Taoyuan District, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
100-3167A3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.